Grantham, Mayo, Van Otterloo & Co (GMO)
NEOG icon

Grantham, Mayo, Van Otterloo & Co (GMO)’s Neogen NEOG Stock Holding History

Grantham, Mayo, Van Otterloo & Co (GMO)’s Portfolio NEOG Stock Details NEOG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-1,441,507
Closed -$12.5M – 663
2025
Q1 		$12.5M Sell
1,441,507
-767,752
-35% -$8.05M 0.04% 217
2024
Q4 		$26.8M Buy
2,209,259
+87,410
+4% +$1.22M 0.09% 156
2024
Q3 		$35.7M Buy
2,121,849
+714,162
+51% +$11.8M 0.11% 127
2024
Q2 		$22M Buy
1,407,687
+339,812
+32% +$4.72M 0.07% 176
2024
Q1 		$16.9M Buy
+1,067,875
New +$17.9M 0.06% 208

Other funds holding NEOG

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CCP
Clarkston Capital Partners Rochester, Michigan $1.31B AUM 3.79% 1-Year Est. Return
GCM
Gates Capital Management New York $3.66B AUM 12.63% 1-Year Est. Return
SCA
Southpoint Capital Advisors New York $4.86B AUM 34.09% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

Grantham, Mayo, Van Otterloo & Co (GMO)'s NEOG Position: Q2 2025 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) sold out of Neogen (NEOG) in Q2 2025, closing a stake of 1,441,507 shares — an estimated $12.5M sold.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in NEOG in Q1 2024 and held it in 5 quarters. The position peaked at $35.7M in Q3 2024. 317 funds tracked by Wall St. Rank hold NEOG as of Q2 2025.

  • Grantham, Mayo, Van Otterloo & Co (GMO) reported no remaining Neogen position as of Q2 2025 after selling out during the quarter.
  • Grantham, Mayo, Van Otterloo & Co (GMO) sold 1,441,507 Neogen shares in Q2 2025, an estimated $12.5M.
  • Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in Neogen in Q1 2024 and held it in 5 quarters.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s Neogen position peaked at $35.7M in Q3 2024.
  • 317 funds tracked by Wall St. Rank held Neogen as of Q2 2025.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q2 2025, filed 13 Aug 2025.